ANDA 88947, held by Pharmafair. Sulfacetamide Sodium.
As of Nov 15, 2026, ANDA 88947 (Sulfacetamide Sodium), held by Pharmafair, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulfacetamide Sodium10% ยท solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
